Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 11/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 8/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 8/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.32 |
| ▸ | HTR3B | O95264 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTR3A | P46098 | 1/20 | 0.32 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.32 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6882959 | 0.94 | CHRNA7 (0.41) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6875498 | 0.93 | CHRNA7 (0.42) | CHRNA7CHRNB2CHRNA4GAAHTR3E | |
| SCHEMBL6884781 | 0.82 | CHRNA7 (0.43) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL7062907 | 0.81 | CHRNA7 (0.39) | CHRNA7CHRNB2CHRNA4HTR3EHTR3B | |
| SCHEMBL6882136 | 0.80 | CHRNA7 (0.42) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6880052 | 0.80 | CHRNA7 (0.41) | CHRNA7CHRNB2CHRNA4GAAHTR3E | |
| SCHEMBL6884326 | 0.79 | CHRNA7 (0.43) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6872580 | 0.79 | CHRNA7 (0.43) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6881872 | 0.79 | CHRNA7 (0.41) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL7063496 | 0.79 | CHRNA7 (0.40) | CHRNA7CHRNB2CHRNA4GAAF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6486172-B2 | ADMINISTERING TO A MAMMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF BENZAMIDE OR BENZOCARBONYLSULFIDE SUBSTITUTED 1-AZABICYCLO(2,2,2)OCT-3-YL COMPOUNDS TO TREAT THE CONDITIONS ASSOCIATED WITH DEFECTS OF NICOTINIC SUBTYPES BRAIN RECEPTORS | PHARMACIA & UPJOHN COMPANY | 2002-11-26 | — | — | US | claimed |